Clinical trial
EVI-1 Expression in Pediatric AML With 11q23 Abnormalities
NCT01057303 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EVI-1 Expression in Pediatric AML With 11q23 Abnormalities
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- June 30, 2010
- Enrollment
- 20 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.